Plasmon’s restructure at ‘advanced stage’; flags £3.7m one-off loss, ’07 pre-tax loss of £15m ahead of share placment

Plasmon plc (PLM.L) said that sales of its UDO products have continued at reduced levels and the restructuring plans outlined in the trading update in early March to discontinue some legacy activities and simplify its operational structure are now at an advanced stage.

It also said that the prospectus for placing 40 million new shares to raise £8m was posted to shareholders yesterday.

Trading update

The Cambridge-based company said in a statement to the London Stock Exchange that since the trading update made on 9 March 2007, it has demonstrated UDO2 technology at the CeBIT trade show on 15 March as planned and also announced a new distribution agreement with Avnet Technology Solutions, a major US IT distributor.

It said the corporate restructuring is expected to result in a one-off charge of £3.7m for the year ended 31 March 2007.

The estimated outcome for the 2007 financial year is for the loss before tax to be approximately £15m, including the restructuring charge.

The loss estimate assumes that the share placing is successful. If is not, the Board said it would be obliged to immediately consider significant additional restructuring of operations, which would be likely to impact the carrying value of certain assets.

The estimate of the loss does not include any additional costs that might result from a failure to complete the share placement.

The 23-year-old company is a specialist in professional data storage, providing a line of UDO drives and media, optical libraries, and Raidtec RAID storage systems for NAS, SCSI and Fibre Channel environments.

It’s share price gained 2.5p to 47.5p, valuing the company at around £39m.

24th April, 2007

Previous articles
ARM launches new small, lowest-power chip
Autonomy acquires records manager Meridio for £20m; reports strong 3Q07 growth
Phytopharm halves after-tax loss; assessing ‘strategic options’
Briefs: DisplayLink to work with WiQuest; 3 top jobs at Velocix
Briefs: Galleon Systems expands into Europe; True Knowledge raises $4m
Angel investor Benthall is new chair of Cambridge Enterprise
Tadpole tumbles as key client reviews strategy; takes big hit on trading, funding
Aveva records another year of strong growth in revenues, profits; outlook positive
Briefs: NextGen to move HQ to US; Alyzime drops development irritable bowel drug
News briefs: CSR’s chip in new Panasonic travel cameras; Amino signs up Oskaloosa IPTV, Cambridge Consultants launch new service for medial device trials
Subscribe

 

Managed Hosting by NTT Managed Hosting
SEO London by IdeaTaxi.com
Corporate profiles

 • Geneservice


Nicholas Leaves BSc, PhD
Operations Director


Geneservice Ltd is a contract research organisation and biological resource centre. In May 2005 it was formed as a limited company in a management buyout of MRC geneservice. Geneservice makes available genomic and proteomic libraries from a wide range of organisms in various formats (e.g. single clones,

[Geneservice's profile]


Top20 Index




Currently: 161